Park Place Capital’s Merck MRK Stock Holding History

Park Place Capital’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$834K	Sell	6,935 -7,279	-51%	-$840K	0.17%	86
2025 Q4	$1.5M	Sell	14,214 -615	-4%	-$57.7K	0.31%	53
2025 Q3	$1.24M	Buy	14,829 +1,514	+11%	+$125K	0.26%	64
2025 Q2	$1.09M	Buy	13,315 +10,386	+355%	+$826K	0.25%	74
2025 Q1	$263K	Sell	2,929 -2,234	-43%	-$209K	0.07%	161
2024 Q4	$514K	Sell	5,163 -2,339	-31%	-$241K	0.14%	119
2024 Q3	$852K	Buy	7,502 +488	+7%	+$58K	0.24%	94
2024 Q2	$868K	Sell	7,014 -2,679	-28%	-$345K	0.28%	78
2024 Q1	$1.28M	Sell	9,693 -3,101	-24%	-$382K	0.46%	56
2023 Q4	$1.39M	Sell	12,794 -1,100	-8%	-$114K	0.56%	50
2023 Q3	$1.43M	Buy	13,894 +728	+6%	+$78.5K	0.42%	52
2023 Q2	$1.52M	Sell	13,166 -441	-3%	-$50.1K	0.43%	47
2023 Q1	$1.45M	Sell	13,607 -4,433	-25%	-$479K	0.41%	53
2022 Q4	$2M	Buy	+18,040	New	+$1.84M	0.56%	35

Other funds holding MRK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Park Place Capital's MRK Position: Q1 2026 in Review

Park Place Capital reduced its Merck (MRK) stake by 51% in Q1 2026, selling an estimated $840K and leaving 6,935 shares worth $834K. The position accounts for 0.17% of the portfolio, ranked #86.

Park Place Capital first reported a position in MRK in Q4 2022 and has held it in 14 quarters since. The position peaked at $2M in Q4 2022. 3,778 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

Park Place Capital held 6,935 shares of Merck worth $834K as of Q1 2026.
Park Place Capital sold 7,279 Merck shares in Q1 2026, an estimated $840K.
Merck made up 0.17% of Park Place Capital's portfolio in Q1 2026, its #86 holding.
Park Place Capital first reported a position in Merck in Q4 2022 and has held it in 14 quarters since.
Park Place Capital's Merck position peaked at $2M in Q4 2022.
3,778 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Park Place Capital's 13F filing for Q1 2026, filed 9 Apr 2026.